Cargando…
Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes
OBJECTIVE: To determine whether IV immunoglobulin (IVIg) is more effective than placebo at reducing disability in patients with diabetes and demyelinating polyneuropathy features. METHODS: This is a double-blinded, single-center, randomized, controlled crossover trial of IVIg treatment vs placebo. T...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943235/ https://www.ncbi.nlm.nih.gov/pubmed/31454771 http://dx.doi.org/10.1212/NXI.0000000000000586 |